Question 1

What is Bio-Techne's P/S ratio?

Accepted Answer

Bio-Techne (TECH) P/S ratio is 6.7× as of June 5, 2026. The ratio is calculated by dividing market capitalisation by trailing twelve-month revenue, using USD-normalised financials (IAS 21 exchange-rate translation for non-USD reporters).

Question 2

How is the P/S ratio calculated?

Accepted Answer

P/S = Market Capitalisation ÷ Trailing Twelve-Month (TTM) Revenue, or equivalently Share Price ÷ TTM Revenue Per Share. All inputs are sourced from audited GAAP/IFRS filings and translated to USD using period-end exchange rates so the multiple is comparable across companies and currencies.

Question 3

What is the P/S ratio?

Accepted Answer

The price-to-sales (P/S) ratio compares a company's market capitalisation to its trailing twelve-month (TTM) revenue. It is calculated as market cap ÷ TTM revenue (equivalent to share price ÷ TTM revenue per share). Because the denominator (revenue) cannot be negative, P/S is widely used to value unprofitable or pre-profit companies and to make cross-sector comparisons.

Question 4

What is a good P/S ratio for Bio-Techne?

Accepted Answer

A "good" P/S depends heavily on profit margin and growth: software and other high-margin businesses often command 5–15× sales, while low-margin retailers and commodity producers typically trade below 1×. Compare against sector peers rather than absolute thresholds. For Bio-Techne specifically, the relevant sector benchmark is the current sector median of 3.5×.

Question 5

Is Bio-Techne's P/S ratio high or low?

Accepted Answer

Bio-Techne's P/S ratio of 6.7× is below its own 5-year average of 11.2× and above the sector median of 3.5×. That places the current reading at the 7th percentile of its 10-year history. A higher multiple usually reflects stronger expected growth, lower perceived risk, or higher returns on capital; a lower multiple reflects the opposite.

Question 6

What is Bio-Techne's historical P/S ratio range?

Accepted Answer

In the available daily series, Bio-Techne (TECH) P/S ratio has ranged from a low of 5.6× in 2026 to a high of 23.7× in 2021. The 5-year average is 11.2× and the 5-year median is 10.2×.

Question 7

What was Bio-Techne's P/S ratio in 2025?

Accepted Answer

Bio-Techne (TECH) P/S ratio at the end of 2025 was 6.5×. Annual values reflect the multiple on the last trading day of each calendar year, using the trailing twelve-month revenue figure available at that date.

Question 8

Why does Bio-Techne's P/S ratio change over time?

Accepted Answer

Valuation multiples move with two inputs: the numerator (market capitalisation, which tracks the share price) and the denominator (revenue). Share-price changes — driven by interest rates, earnings expectations, risk appetite, and broader market sentiment — typically dominate short-term moves, while changes in the underlying fundamental drive the longer-term trend. As a result, the ratio can rise during stock-price rallies even if the business itself has not become more valuable, and fall during sell-offs even when fundamentals are improving.


2025	$7.97B	$1.22B	6.5×	-3.2×	Jun 30, 2025
2024	$11.30B	$1.16B	9.8×	-1.6×	Jun 30, 2024
2023	$12.86B	$1.14B	11.3×	-1.0×	Jun 30, 2023
2022	$13.59B	$1.11B	12.3×	-6.5×	Jun 30, 2022
2021	$17.52B	$931.03M	18.8×	+5.1×	Jun 30, 2021
2020	$10.12B	$738.69M	13.7×	+2.6×	Jun 30, 2020
2019	$7.93B	$714.00M	11.1×	+2.5×	Jun 30, 2019
2018	$5.56B	$642.99M	8.6×	+0.9×	Jun 30, 2018
2017	$4.39B	$563.00M	7.8×	-0.6×	Jun 30, 2017
2016	$4.20B	$499.02M	8.4×	+0.3×	Jun 30, 2016
2015	$3.66B	$452.25M	8.1×	-1.5×	Jun 30, 2015
2014	$3.42B	$357.76M	9.6×	+1.3×	Jun 30, 2014
2013	$2.57B	$310.57M	8.3×	-0.4×	Jun 30, 2013
2012	$2.73B	$314.56M	8.7×	-2.0×	Jun 30, 2012
2011	$3.09B	$289.96M	10.7×	+2.8×	Jun 30, 2011
2010	$2.13B	$269.05M	7.9×	-1.1×	Jun 30, 2010
2009	$2.38B	$263.96M	9.0×	-2.6×	Jun 30, 2009
2008	$2.99B	$257.42M	11.6×	+1.5×	Jun 30, 2008
2007	$2.26B	$223.48M	10.1×	+0.2×	Jun 30, 2007
2006	$2.01B	$202.62M	9.9×	-0.1×	Jun 30, 2006
2005	$1.78B	$178.65M	10.0×	-1.1×	Jun 30, 2005
2004	$1.79B	$161.26M	11.1×	+2.5×	Jun 30, 2004
2003	$1.24B	$145.01M	8.6×	-0.2×	Jun 30, 2003
2002	$1.15B	$130.90M	8.8×	—	Jun 30, 2002


Zimmer Biomet Holdings (ZBH)	2.1×
AptarGroup (ATR)	2.1×
Becton, Dickinson and (BDX)	2.1×
Charles River (CRL)	1.9×
Quest Diagnostics (DGX)	1.9×
IQVIA (IQV)	1.7×
GE HealthCare (GEHC)	1.6×
Labcorp Holdings (LH)	1.6×
HCA Healthcare (HCA)	1.4×
Solventum (SOLV)	1.4×
Viatris (VTRS)	1.1×
Baxter International (BAX)	0.8×
DaVita (DVA)	0.7×
Henry Schein (HSIC)	0.6×
Universal Health Services (UHS)	0.6×
UnitedHealth Group (UNH)	0.5×
Elevance Health (ELV)	0.3×
McKesson (MCK)	0.3×
Cigna (CI)	0.3×
CVS Health (CVS)	0.2×
Cardinal Health (CAH)	0.2×
Cencora (COR)	0.2×
Humana (HUM)	0.2×
Molina Healthcare (MOH)	0.2×
Centene (CNC)	0.1×

P/S Ratio for Bio-Techne (TECH)

P/S Ratio daily chart for Bio-Techne (TECH)

Historical P/S Ratio for Bio-Techne (TECH) from 2002 to 2025

About P/S Ratio at Bio-Techne (TECH)

Bio-Techne P/S Ratio by Year

Bio-Techne P/S Ratio 2025: 6.5×

Bio-Techne P/S Ratio 2024: 9.8×

Bio-Techne P/S Ratio 2023: 11.3×

Bio-Techne P/S Ratio 2022: 12.3×

Bio-Techne P/S Ratio 2021: 18.8×

Sector peers by P/S Ratio — chart

Sector peers by P/S Ratio — table

Frequently asked questions

Bio-Techne (TECH) Key Financials

P/S Ratio daily chart for Bio-Techne (TECH)

Historical P/S Ratio for Bio-Techne (TECH) from 2002 to 2025

About P/S Ratio at Bio-Techne (TECH)

Bio-Techne P/S Ratio by Year

Bio-Techne P/S Ratio 2025: 6.5×

Bio-Techne P/S Ratio 2024: 9.8×

Bio-Techne P/S Ratio 2023: 11.3×

Bio-Techne P/S Ratio 2022: 12.3×

Bio-Techne P/S Ratio 2021: 18.8×

Sector peers by P/S Ratio — chart

Sector peers by P/S Ratio — table

Frequently asked questions

+What is Bio-Techne's P/S ratio?

+How is the P/S ratio calculated?

+What is the P/S ratio?

+What is a good P/S ratio for Bio-Techne?

+Is Bio-Techne's P/S ratio high or low?

+What is Bio-Techne's historical P/S ratio range?

+What was Bio-Techne's P/S ratio in 2025?

+Why does Bio-Techne's P/S ratio change over time?

Bio-Techne (TECH) Key Financials